PROMETHACON Drug Patent Profile
✉ Email this page to a colleague
When do Promethacon patents expire, and what generic alternatives are available?
Promethacon is a drug marketed by Polymedica and is included in two NDAs.
The generic ingredient in PROMETHACON is promethazine hydrochloride. There are twelve drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Promethacon
A generic version of PROMETHACON was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.
Summary for PROMETHACON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Patent Applications: | 2,256 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROMETHACON at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PROMETHACON
US Patents and Regulatory Information for PROMETHACON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polymedica | PROMETHACON | promethazine hydrochloride | SUPPOSITORY;RECTAL | 084901-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Polymedica | PROMETHACON | promethazine hydrochloride | SUPPOSITORY;RECTAL | 084902-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |